Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Antiviral Res. 2009 Mar 11;83(1):21–27. doi: 10.1016/j.antiviral.2009.02.20

Figure 5.

Figure 5

A) Effect of 25 μg/ml of either guanidinylated analog of geneticin (gG418) or geneticin on viability of cells infected with DENV-2. Cell viability is expressed as percent survival (see Experimental Procedures). Data are presented as means ± SE for each aminoglycoside (n=3, triplicates for individual experiment). B) Antiviral property of geneticin against DENV-2 and cytotoxicity of geneticin in the Neor-containing BHK cells. Top panel, Neor -BHK cells were infected with DENV-2 at an MOI of 1 and 96 hpi cell viability in the presence of geneticin was determined by Almar Blue assay and was presented as percentage of cell survival compared to viral infection without drug (Data are presented as means ± SE; n=6 with triplicates of each experiment). Bottom Panal, Neor-BHK cells were incubated with geneticin at different concentration for 96 hrs and cell viability was measured by Almar Blue assay and was expressed by percentage of survival to control (Data are presented as means ± SE; n=6 with triplicates samples each individual experiments).